SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-011464
Filing Date
2016-08-03
Accepted
2016-08-03 16:06:52
Documents
93
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_080316p.htm 10-Q 660942
2 EXHIBIT 10.1 exh_101.htm EX-10.1 151307
3 EXHIBIT 31.1 exh_311.htm EX-31.1 9121
4 EXHIBIT 31.2 exh_312.htm EX-31.2 9096
5 EXHIBIT 32.1 exh_321.htm EX-32.1 3353
6 EXHIBIT 32.2 exh_322.htm EX-32.2 3311
  Complete submission text file 0001171843-16-011464.txt   5532586

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE scmp-20160630.xml EX-101.INS 842550
8 XBRL SCHEMA FILE scmp-20160630.xsd EX-101.SCH 75617
9 XBRL CALCULATION FILE scmp-20160630_cal.xml EX-101.CAL 56131
10 XBRL DEFINITION FILE scmp-20160630_def.xml EX-101.DEF 590373
11 XBRL LABEL FILE scmp-20160630_lab.xml EX-101.LAB 437838
12 XBRL PRESENTATION FILE scmp-20160630_pre.xml EX-101.PRE 610605
Mailing Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850
Business Address 805 KING FARM BOULEVARD, SUITE 550 ROCKVILLE MD 20850 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 161803848
SIC: 2834 Pharmaceutical Preparations